Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika M Bruger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 2, 2021
MDSC in Mice and Men: Mechanisms of Immunosuppression in CancerChristophe Vanhaver, Pierre van der Bruggen, Annika M Bruger
Blood|June 8, 2018
Extracellular galectins as controllers of cytokines in hematological cancerMonica Gordon-Alonso, Annika M Bruger, Pierre van der Bruggen
Methods in Enzymology|January 18, 2020
Reverse immunology: From peptide sequence to tumor-killing human T-cell clonesChristophe Vanhaver, Monica Gordon-Alonso, Alexandre Bayard, et al.
Methods in Enzymology|February 1, 2020
Protocol to assess the suppression of T-cell proliferation by human MDSCAnnika M Bruger, Christophe Vanhaver, Kirsten Bruderek, et al.
Life Science Alliance|November 6, 2023
Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotypeChristophe Vanhaver, Frank Aboubakar Nana, Nicolas Delhez, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2018
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutionsAnnika M Bruger, Anca Dorhoi, Gunes Esendagli, et al.
Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.
The EMBO Journal|December 24, 2014
A THEMIS:SHP1 complex promotes T-cell survivalWolfgang Paster, Annika M Bruger, Kristin Katsch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 2, 2021
MDSC in Mice and Men: Mechanisms of Immunosuppression in CancerChristophe Vanhaver, Pierre van der Bruggen, Annika M Bruger
Blood|June 8, 2018
Extracellular galectins as controllers of cytokines in hematological cancerMonica Gordon-Alonso, Annika M Bruger, Pierre van der Bruggen
Methods in Enzymology|January 18, 2020
Reverse immunology: From peptide sequence to tumor-killing human T-cell clonesChristophe Vanhaver, Monica Gordon-Alonso, Alexandre Bayard, et al.
Methods in Enzymology|February 1, 2020
Protocol to assess the suppression of T-cell proliferation by human MDSCAnnika M Bruger, Christophe Vanhaver, Kirsten Bruderek, et al.
Life Science Alliance|November 6, 2023
Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotypeChristophe Vanhaver, Frank Aboubakar Nana, Nicolas Delhez, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2018
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutionsAnnika M Bruger, Anca Dorhoi, Gunes Esendagli, et al.
Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.
The EMBO Journal|December 24, 2014
A THEMIS:SHP1 complex promotes T-cell survivalWolfgang Paster, Annika M Bruger, Kristin Katsch, et al.
Pageof 1